Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer
Tallac Therapeutics, a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity […]
VectorY and Annogen Announce Research Collaboration for the Development of CNS-cell Specific Promoters
VectorY Therapeutics, a biotech company developing innovative vectorized antibody therapies for the treatment of neurodegenerative […]
Machine Solutions Acquires Vela Technologies
Machine Solutions, a provider of advanced equipment and services for the medical device market, has […]
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
NeuroBo Pharmaceuticals, a clinical-stage biotechnology company focused on therapies for cardiometabolic diseases, today announced that it […]
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
Cryoport, a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences […]
CureLab Veterinary Launches Equity Crowdfunding Campaign on Netcapital to Revolutionize Medicine for Dogs, Cats, and Horses
CureLab Veterinary, an emerging animal health biotech company, has launched its crowdfunding campaign via Netcapital, […]
Asieris Appoints Dr. Linda Wu as Chief Development Officer
Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for […]
InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux
InDevR, a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has […]
Optibrium Appoints Steve Yemm as Chief Commercial Officer
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the […]
Amylyx Pharmaceuticals Announces Exclusive AMX0035 Distribution Agreement with Israel-Based Neopharm
Amylyx Pharmaceuticals today announced it has entered into an exclusive license and distribution agreement with […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more